VASCULAR SURGERY

Options for Esophageal Replacement

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Options for Esophageal Replacement

Introduction Print Section Listen Reestablishing gastrointestinal continuity after esophagectomy can be challenging for patient and surgeon alike. There are no perfect substitutes, since every reconstructive alternative is inferior to the…

read more

Management of Malignant Esophageal Fistula

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Management of Malignant Esophageal Fistula

Introduction Print Section Listen Malignant esophageal fistula occurs infrequently, yet remains one of the most challenging complications encountered in thoracic oncology. It may occur in the setting of complicated esophageal…

read more

Salvage Surgery for Recurrent Esophageal Cancer

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Salvage Surgery for Recurrent Esophageal Cancer

Introduction Print Section Listen Recurrent (after a disease-free period) or persistent esophageal cancer following definitive therapy, particularly for locally advanced cancer, is common. Treatment failure following definitive chemoradiotherapy in RTOG-8501…

read more

Left Thoracoabdominal Approach

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Left Thoracoabdominal Approach

Introduction Print Section Listen A thoracoabdominal approach to resection of the esophagus is most useful with tumors of the distal esophagus that lie inferior to the aortic arch as well…

read more

Three-Field Esophagectomy

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Three-Field Esophagectomy

Introduction Print Section Listen The esophagus traverses the neck, mediastinum, and abdomen. Cancer of the thoracic esophagus can metastasize to lymph nodes and locate in any or all of these…

read more

Pathology of Esophageal Cancer

Dec 30, 2018 by in VASCULAR SURGERY Comments Off on Pathology of Esophageal Cancer

Introduction Print Section Listen Esophageal cancer is a gastrointestinal malignancy that encompasses a range of pathologic entities. Squamous cell carcinomas constitute at least 90% of all cancers worldwide.1 Adenocarcinoma is…

read more
Get Clinical Tree app for offline access